Why is Astrazeneca Phar falling/rising?

As of 02-Jul, Astrazeneca Pharma India Ltd's stock price is rising, currently at Rs 9,011.05, reflecting an increase of Rs 121.05 or 1.36%. The stock has shown a trend reversal, gaining after two consecutive days of decline. It outperformed its sector by 1.28% today and reached an intraday high of Rs 9,239.25, which is a 3.93% increase. Over the past week, the stock has risen by 1.65%, although it has seen a decline of 3.27% over the past month. The company has demonstrated strong financial performance, with a net profit growth of 88.82% and positive results over the last two quarters. However, there are concerns regarding falling investor participation, as delivery volume has decreased significantly.
In the broader market context, Astrazeneca's short-term performance has outpaced the Sensex, which has increased by 0.79% over the same week. Despite the stock's impressive year-to-date return of 22.85% compared to the Sensex's 6.75%, there are risks associated with its high valuation and declining institutional investor participation. The company's high ROE of 19.06% and consistent returns over the last three years contribute positively to its outlook, but the relatively poor long-term growth rate of operating profit raises concerns. Overall, while the stock is currently rising, it faces challenges that could impact its future performance.